Pembrolizumab Plus Amrubicin in Patients With Relapsed SCLC: Multi-Institutional, Single-Arm Phase 2 Study
暂无分享,去创建一个
N. Yamamoto | K. Nakagawa | H. Akamatsu | H. Hayashi | T. Shimokawa | D. Fujimoto | K. Haratani | A. Hayata | Y. Ozawa | K. Tomii | T. Iwasa | Takeshi Yoshida | S. Teraoka | Tsutomu Iwasa